Home » Functional Assays Improve Classification of Potential Cystic Fibrosis Risk Variants

Functional Assays Improve Classification of Potential Cystic Fibrosis Risk Variants

May 24, 2018
|
staff reporter

NEW YORK (GenomeWeb) – A new analysis of missense variants implicated in the expression of cystic fibrosis (CF) has again highlighted the importance of applying appropriate functional assays to classify such variants and their potential impact in the clinic.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Scan

The Same Genes Keep Getting Asked to Prom

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

Keep Them in the Know

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

From Tusk to Cartel

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

This Week in Nature

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.

What's Popular?

In Clinical Sequencing

  1. Nanopore Sequencing Becomes More Portable to Enable Outbreak Surveillance in Field

    Premium

  2. Survey Finds QC Best Practices in Clinical Genomics Still Developing

  3. Families Declining Enrollment in BabySeq Cite Lack of Interest in Research, Logistical Challenges

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.